Symposium: Research Pathology in Drug R&D and Biotech

Symposium: Research Pathology in Drug R&D and Biotech

Saturday, April 2, 2022 • 8:30 AM - 11:00 AM (EDT)

Pennsylvania Convention Center, Room 115-A

Sponsored by the ASIP Pathology in Biotech and Industry Scientific Interest Group


Cary Austin, MD, PhDChair
Cary Austin, MD, PhD

Shawn O’Neil, DVM, PhDCo-Chair
Shawn O’Neil, DVM, PhD


  Chair - Welcome and Introductions  
8:30 AM - 9:00 AM

Targeting Kallikrein-Related Peptidases as a Therapeutic Strategy for Netherton’s Syndrome and Atopic Dermatitis

Cary Austin, MD, PhD • Genentech, Inc.

Cary Austin, MD, PhD
9:00 AM - 9:30 AM

Advancing Individualized Neoantigen Specific Therapies and Elucidating Tumor Evolution Using Tissue Based Techniques

Amy Lo, MD, MS • Genentech, Inc.

Amy Lo, MD, MS
9:30 AM - 10:00 AM

Integration of Multiplex Tissue Analyte Labeling into the Anatomic Pathology Workflow

Keith Wharton, Jr., MD, PhD • Ultivue, Inc.
Keith Wharton, MD, PhD
10:00 AM - 10:30 AM

Spatial Gene Expression in Histologic Sections Using Visium: Lessons Learned from Examination of Hidradenitis Supprativa

Susan Westmoreland, VMD • AbbVie, Inc.

Susan Westmoreland, VMD
10:30 AM - 11:00 AM

Use of Mass Spectrometry to Localize and Quantify Test Articles in Tissue Sections

Shawn O'Neil, DVM, PhD • Pfizer, Inc
Shawn O’Neil, DVM, PhD
  Questions & Answers